{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:02:33Z","timestamp":1793318553587,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jinf.2022.11.005","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T20:38:49Z","timestamp":1668544729000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA)"],"prefix":"10.1016","volume":"86","author":[{"given":"PDE","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SR","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-675X","authenticated-orcid":false,"given":"R","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6506-2689","authenticated-orcid":false,"given":"K","family":"Jeffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-6999","authenticated-orcid":false,"given":"A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PT","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-3925","authenticated-orcid":false,"given":"K","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6819-3476","authenticated-orcid":false,"given":"JA","family":"Snowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TI","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2022.11.005_bib0001","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/infdis\/162.2.496","article-title":"Response to tetanus toxoid immunization after allogeneic bone marrow transplantation","volume":"162","author":"Ljungman","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0002","first-page":"89","article-title":"Response to immunization against polio after allogeneic marrow transplantation","volume":"7","author":"Ljungman","year":"1991","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jinf.2022.11.005_bib0003","first-page":"295","article-title":"Immune response to polio vaccination in bone marrow transplant recipients","volume":"8","author":"Engelhard","year":"1991","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jinf.2022.11.005_bib0004","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.bmt.1700959","article-title":"Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT","volume":"20","author":"Parkkali","year":"1997","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jinf.2022.11.005_bib0005","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/archinte.1983.00350090113018","article-title":"Pneumococcal vaccination of recipients of bone marrow transplants","volume":"143","author":"Winston","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2022.11.005_bib0006","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/infdis\/154.4.590","article-title":"Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine","volume":"154","author":"Giebink","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0007","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V84.2.657.657","article-title":"Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation","volume":"84","author":"Ljungman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2022.11.005_bib0008","first-page":"427","article-title":"Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation","volume":"9","author":"Pauksen","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0009","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/159.4.610","article-title":"Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine","volume":"159","author":"Ljungman","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0010","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1016\/j.vaccine.2021.07.022","article-title":"Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant","volume":"39","author":"Colton","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2022.11.005_bib0011","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0012","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3324\/haematol.2011.041913","article-title":"Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients","volume":"96","author":"Ljungman","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jinf.2022.11.005_bib0013","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.bmt.1705964","article-title":"Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance","volume":"41","author":"Kumar","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0014","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bmt.1705318","article-title":"Pertussis: should we vaccinate post transplant?","volume":"37","author":"Kochethu","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/00007890-199510150-00010","article-title":"Bacterial pneumonia in recipients of bone marrow transplantation","volume":"60","author":"Lossos","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2022.11.005_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0017","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0018","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0019","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2011.02.018","article-title":"Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the International consensus conference on clinical practice in chronic GVHD","volume":"29","author":"Hilgendorf","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2022.11.005_bib0020","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European conference on infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0021","unstructured":"Patel S.R., Skinner R., Heath P. Vaccinations for paediatric patients treated with standard-dose chemotherapy and haematopoietic stem cell transplantation (HSCT) recipients."},{"key":"10.1016\/j.jinf.2022.11.005_bib0022","unstructured":"Health RC of P and C. Immunisation of the immunocompromised child. 2002."},{"key":"10.1016\/j.jinf.2022.11.005_bib0023","first-page":"S614","article-title":"Vaccination against Infection after Haematopoietic stem cell transplant\u00a0: a survey of practice in the UK and Ireland","volume":"21","author":"Gilleece","year":"2007","journal-title":"BBMT"},{"key":"10.1016\/j.jinf.2022.11.005_bib0024","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/bmt.2016.362","article-title":"Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes","volume":"52","author":"Miller","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41409-020-01067-y","article-title":"Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years","volume":"56","author":"Dignan","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0026","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/pbc.22415","article-title":"CCLG) SCG of the CC and LG. Immunisation practices of paediatric oncology and shared care oncology consultants: a United Kingdom survey","volume":"54","author":"Bate","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jinf.2022.11.005_bib0027","first-page":"203","article-title":"A study of adherence to a vaccination schedule following adult allogeneic haematopoietic stem cell transplants in UK","author":"Meiring","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0028","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-021222","article-title":"Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model","volume":"8","author":"Miller","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jinf.2022.11.005_bib0029","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.bmt.1704048","article-title":"Respiratory viral infections after bone marrow\/peripheral stem-cell transplantation: the Christie hospital experience","volume":"32","author":"Hassan","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0030","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/425004","article-title":"Influenza infections after hematopoietic stem cell transplantation\u00a0: risk factors, mortality, and the effect of antiviral therapy","volume":"39","author":"Nichols","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0031","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2141.2002.03457.x","article-title":"Early and late invasive pneumococcal infection following stem cell transplantation: a European bone marrow transplantation survey","volume":"117","author":"Engelhard","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jinf.2022.11.005_bib0032","first-page":"1","article-title":"Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients","volume":"11","author":"Engelhard","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0033","doi-asserted-by":"crossref","unstructured":"Natori Y., Humar A., Lipton J., Kim D., Hoschler K., Ashton P. et\u00a0al. A pilot randomized controlled trial of Adjuvanted vs. Nonadjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients. In: IDWeek. New Orleans, 2016.","DOI":"10.1093\/ofid\/ofw172.1058"},{"key":"10.1016\/j.jinf.2022.11.005_bib0034","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbmt.2012.08.015","article-title":"A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation","volume":"19","author":"Karras","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0035","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.vaccine.2010.12.113","article-title":"The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A\/California\/7\/2009 (H1N1)v-like virus vaccine during the 2009 pandemic","volume":"29","author":"Engelhard","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2022.11.005_bib0036","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbmt.2012.08.015","article-title":"A randomized trial of one Vs. Two doses of influenza vaccine following allogeneic transplantation","volume":"19","author":"Karras","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0037","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.vaccine.2018.11.061","volume":"37","author":"Miller","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2022.11.005_bib0038","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1086\/598324","article-title":"Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0039","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/petr.12361","article-title":"Analysis of factors affecting immune recovery and initial response to tetanus after DTaP vaccination in pediatric allogeneic HSCT patients","volume":"18","author":"Boles","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0040","first-page":"961","article-title":"A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT","volume":"18","author":"Parkkali","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0041","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/cid\/civ287","article-title":"Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged =2 years: an open-label study","volume":"61","author":"Cordonnier","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0042","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.bmt.1705562","article-title":"A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation","volume":"39","author":"Parkkali","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0043","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.vaccine.2010.01.025","article-title":"Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial","volume":"28","author":"Cordonnier","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2022.11.005_bib0044","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbmt.2011.07.027","article-title":"Safety and immunogenicity of the tetravelent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic stem cell transplantation (alloHSCT)","volume":"18","author":"Mahler","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0045","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/infdis\/166.5.1021","article-title":"Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients","volume":"166","author":"Barra","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0046","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/TP.0b013e3181772a75","article-title":"Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation","volume":"86","author":"Avetisyan","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jinf.2022.11.005_bib0047","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3324\/haematol.2011.040386","article-title":"Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A\/09\/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients","volume":"96","author":"Mohty","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jinf.2022.11.005_bib0048","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3324\/haematol.2010.032664","article-title":"Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host","volume":"96","author":"Lavallade de","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jinf.2022.11.005_bib0049","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood-2006-06-032284","article-title":"Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation","volume":"109","author":"Meisel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2022.11.005_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103705","article-title":"Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial","volume":"74","author":"Bergman","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jinf.2022.11.005_bib0051","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41409-019-0684-0","volume":"55","author":"Sharrack","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0052","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41409-020-0931-4","article-title":"COVID-19 outcomes in patients with hematologic disease","volume":"55","author":"Malard","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0053","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1111\/bjh.16856","article-title":"COVID-19 in bone marrow transplant recipients: reflecting on a single centre experience","volume":"190","author":"Kanellopoulos","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jinf.2022.11.005_bib0054","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bmt.1700768","article-title":"A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT","volume":"19","author":"Parkkali","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0055","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood.V112.11.2214.2214","article-title":"Use of the tetanus toxoid, reduced dose diphtheria and pertussis vaccine (Tdap) in allogeneic transplant (alloHCT) recipients","volume":"112","author":"Papadopoulos","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2022.11.005_bib0056","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.bbmt.2009.07.018","article-title":"Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation","volume":"15","author":"Small","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0057","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.bmt.1701424","article-title":"Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation","volume":"22","author":"Vance","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0058","unstructured":"Royal College of Physician of Ireland, Immunisation guidelines for Ireland 2013. 2013.http:\/\/www.hse.ie\/eng\/health\/immunisation\/hcpinfo\/guidelines\/."},{"key":"10.1016\/j.jinf.2022.11.005_bib0059","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1182\/blood-2006-04-006981","article-title":"Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants","volume":"108","author":"Jaffe","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2022.11.005_bib0060","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/bloodadvances.2018018911","article-title":"Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation","volume":"2","author":"Cheng","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jinf.2022.11.005_bib0061","first-page":"195","article-title":"Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction","volume":"1","author":"Hammarstrom","year":"1993","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jinf.2022.11.005_bib0062","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1086\/523583","article-title":"A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients","volume":"45","author":"Kumar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0063","unstructured":"PublicHealth England, Green Book Human Papillomavirus chapter 18a, PublicHealth England. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1065283\/HPV-greenbook-chapter-18a.pdf (accessed 8 May2022)."},{"key":"10.1016\/j.jinf.2022.11.005_bib0064","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","article-title":"HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial","volume":"95","author":"Kitchener","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jinf.2022.11.005_bib0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/bmt.2017.210","article-title":"Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study","volume":"53","author":"Shanis","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0066","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbmt.2008.07.005","article-title":"Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation\u2014implications for screening and HPV vaccination","volume":"14","author":"Savani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0067","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaoncol.2019.6722","article-title":"Immune response following quadrivalent human papillomavirus vaccination in women after hematopoietic allogeneic stem cell transplant","volume":"6","author":"Stratton","year":"2020","journal-title":"Jama Oncol"},{"key":"10.1016\/j.jinf.2022.11.005_bib0068","series-title":"Green Book Chapter 19 -\u00a0 Influenza","year":"2020"},{"key":"10.1016\/j.jinf.2022.11.005_bib0069","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/313663","article-title":"Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients","volume":"30","author":"Pauksen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0070","first-page":"437","article-title":"Influenza A virus infections among hospitalized adult bone marrow transplant recipients","volume":"13","author":"Whimbey","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0071","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood.2021012769","article-title":"Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy","volume":"138","author":"Dhakal","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2022.11.005_bib0072","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(21)01594-4","article-title":"Antibody response after second BNT162b2 dose in allogeneic HSCT recipients","volume":"398","author":"Redjoul","year":"2021","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jinf.2022.11.005_bib0073","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jtct.2021.06.024","article-title":"Safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients after allogeneic HCT or CD19-based CART therapy\u2014a single-center prospective cohort study","volume":"27","author":"Ram","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jinf.2022.11.005_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.737300","article-title":"Immunological response against SARS-COV-2 after BNT162b2 vaccine administration is impaired in allogeneic but not in autologous stem cell transplant recipients","volume":"11","author":"Chiarucci","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jinf.2022.11.005_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(21)00169-1","article-title":"Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study","author":"Maneikis","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jinf.2022.11.005_bib0076","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2022.11.005_bib0077","series-title":"Green Book Chapter 6 - Contraindications and Special Considerations","year":"2017"},{"key":"10.1016\/j.jinf.2022.11.005_bib0078","unstructured":"Public Health England, Green book - Chapter 11 - the UK immunisation schedule, Public Health England. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/855727\/Greenbook_chapter_11_UK_Immunisation_schedule.pdf (accessed 19 Jun2021)."},{"key":"10.1016\/j.jinf.2022.11.005_bib0079","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1111\/j.1651-2227.2012.02710.x","article-title":"Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation","volume":"101","author":"Olkinuora","year":"2012","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jinf.2022.11.005_bib0080","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.bbmt.2015.08.010","article-title":"Robust vaccine responses in adult and pediatric cord blood transplantation recipients treated for hematologic malignancies","volume":"21","author":"Shah","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0081","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/511641","article-title":"Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation","volume":"44","author":"Patel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0082","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/bmt.2010.31","article-title":"Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs","volume":"45","author":"Kussmaul","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0083","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.bbmt.2011.05.006","article-title":"Safety and efficacy of the live attenuated varicella vaccine following T replete or T cell depleted related and unrelated haematopoietic cell transplantation","volume":"17","author":"Chou","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2022.11.005_bib0084","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/tid.12295","article-title":"Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation","volume":"16","author":"Sasadeusz","year":"2014","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa0904485","article-title":"Vaccine-acquired rotavirus in infants with severe combined immunodeficiency","volume":"362","author":"Patel","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jinf.2022.11.005_bib0086","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/infdis\/jix564","article-title":"Immunogenicity and safety of yellow fever vaccine in allogeneic hematopoietic stem cell transplant recipients after withdrawal of immunosuppressive therapy","volume":"217","author":"de Fontbrune","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.005_bib0087","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1708-8305.2009.00336.x","article-title":"Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow fever vaccine","volume":"16","author":"Yax","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.jinf.2022.11.005_bib0088","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0609.2004.00218.x","article-title":"Yellow fever vaccine: a successful vaccination of an immunocompromised patient","volume":"72","author":"Gowda","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jinf.2022.11.005_bib0089","series-title":"Quality Management and Accreditation in Haematopoietic Stem Cell Transplantation and Cellular Therapy: The JACIE Guide","author":"Snowden","year":"2021"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:35:22Z","timestamp":1759008922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445322006466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0163445322006466"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2022.11.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA)","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}